Literature DB >> 19745295

A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project.

Paul Avillach1, Fleur Mougin, Michel Joubert, Frantz Thiessard, Antoine Pariente, Jean-Charles Dufour, Gianluca Trifirò, Giovanni Polimeni, Maria Antonietta Catania, Carlo Giaquinto, Giampiero Mazzaglia, Gianluca Baio, Ron Herings, Rosa Gini, Julia Hippisley-Cox, Mariam Molokhia, Lars Pedersen, Annie Fourrier-Réglat, Miriam Sturkenboom, Marius Fieschi.   

Abstract

The overall objective of the eu-ADR project is the design, development, and validation of a computerised system that exploits data from electronic health records and biomedical databases for the early detection of adverse drug reactions. Eight different databases, containing health records of more than 30 million European citizens, are involved in the project. Unique queries cannot be performed across different databases because of their heterogeneity: Medical record and Claims databases, four different terminologies for coding diagnoses, and two languages for the information described in free text. The aim of our study was to provide database owners with a common basis for the construction of their queries. Using the UMLS, we provided a list of medical concepts, with their corresponding terms and codes in the four terminologies, which should be considered to retrieve the relevant information for the events of interest from the databases.

Entities:  

Mesh:

Year:  2009        PMID: 19745295

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  11 in total

1.  Terminological challenges in safety surveillance.

Authors:  Andrew Bate; Elliot G Brown; Stephen A Goldman; Manfred Hauben
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

2.  Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network.

Authors:  Carmen Ferrajolo; Preciosa M Coloma; Katia M C Verhamme; Martijn J Schuemie; Sandra de Bie; Rosa Gini; Ron Herings; Giampiero Mazzaglia; Gino Picelli; Carlo Giaquinto; Lorenza Scotti; Paul Avillach; Lars Pedersen; Francesco Rossi; Annalisa Capuano; Johan van der Lei; Gianluca Trifiró; Miriam C J M Sturkenboom
Journal:  Drug Saf       Date:  2014-02       Impact factor: 5.606

3.  The role of electronic healthcare record databases in paediatric drug safety surveillance: a retrospective cohort study.

Authors:  Sandra de Bie; Preciosa M Coloma; Carmen Ferrajolo; Katia M C Verhamme; Gianluca Trifirò; Martijn J Schuemie; Sabine M J M Straus; Rosa Gini; Ron Herings; Giampiero Mazzaglia; Gino Picelli; Arianna Ghirardi; Lars Pedersen; Bruno H C Stricker; Johan van der Lei; Miriam C J M Sturkenboom
Journal:  Br J Clin Pharmacol       Date:  2015-05-20       Impact factor: 4.335

4.  Evaluation of Electronic Healthcare Databases for Post-Marketing Drug Safety Surveillance and Pharmacoepidemiology in China.

Authors:  Yu Yang; Xiaofeng Zhou; Shuangqing Gao; Hongbo Lin; Yanming Xie; Yuji Feng; Kui Huang; Siyan Zhan
Journal:  Drug Saf       Date:  2018-01       Impact factor: 5.606

5.  Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project.

Authors:  Paul Avillach; Preciosa M Coloma; Rosa Gini; Martijn Schuemie; Fleur Mougin; Jean-Charles Dufour; Giampiero Mazzaglia; Carlo Giaquinto; Carla Fornari; Ron Herings; Mariam Molokhia; Lars Pedersen; Annie Fourrier-Réglat; Marius Fieschi; Miriam Sturkenboom; Johan van der Lei; Antoine Pariente; Gianluca Trifirò
Journal:  J Am Med Inform Assoc       Date:  2012-09-06       Impact factor: 4.497

6.  Automatic filtering and substantiation of drug safety signals.

Authors:  Anna Bauer-Mehren; Erik M van Mullingen; Paul Avillach; María Del Carmen Carrascosa; Ricard Garcia-Serna; Janet Piñero; Bharat Singh; Pedro Lopes; José L Oliveira; Gayo Diallo; Ernst Ahlberg Helgee; Scott Boyer; Jordi Mestres; Ferran Sanz; Jan A Kors; Laura I Furlong
Journal:  PLoS Comput Biol       Date:  2012-04-05       Impact factor: 4.475

7.  Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues?

Authors:  Vera E Valkhoff; René Schade; Geert W 't Jong; Silvana Romio; Martijn J Schuemie; Andrea Arfe; Edeltraut Garbe; Ron Herings; Silvia Lucchi; Gino Picelli; Tania Schink; Huub Straatman; Marco Villa; Ernst J Kuipers; Miriam C J M Sturkenboom
Journal:  BMC Pediatr       Date:  2013-11-19       Impact factor: 2.125

8.  Data Extraction and Management in Networks of Observational Health Care Databases for Scientific Research: A Comparison of EU-ADR, OMOP, Mini-Sentinel and MATRICE Strategies.

Authors:  Rosa Gini; Martijn Schuemie; Jeffrey Brown; Patrick Ryan; Edoardo Vacchi; Massimo Coppola; Walter Cazzola; Preciosa Coloma; Roberto Berni; Gayo Diallo; José Luis Oliveira; Paul Avillach; Gianluca Trifirò; Peter Rijnbeek; Mariadonata Bellentani; Johan van Der Lei; Niek Klazinga; Miriam Sturkenboom
Journal:  EGEMS (Wash DC)       Date:  2016-02-08

9.  Gathering and exploring scientific knowledge in pharmacovigilance.

Authors:  Pedro Lopes; Tiago Nunes; David Campos; Laura Ines Furlong; Anna Bauer-Mehren; Ferran Sanz; Maria Carmen Carrascosa; Jordi Mestres; Jan Kors; Bharat Singh; Erik van Mulligen; Johan Van der Lei; Gayo Diallo; Paul Avillach; Ernst Ahlberg; Scott Boyer; Carlos Diaz; José Luís Oliveira
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

10.  Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project.

Authors:  Gwen M C Masclee; Huub Straatman; Andrea Arfè; Jordi Castellsague; Edeltraut Garbe; Ron Herings; Bianca Kollhorst; Silvia Lucchi; Susana Perez-Gutthann; Silvana Romio; René Schade; Tania Schink; Martijn J Schuemie; Lorenza Scotti; Cristina Varas-Lorenzo; Vera E Valkhoff; Marco Villa; Miriam C J M Sturkenboom
Journal:  PLoS One       Date:  2018-11-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.